# FIBrinogen REplenishment in Surgery

> **NCT03037424** · PHASE3 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 827 (actual)

## Conditions studied

- Deficiency; Fibrinogen, Acquired

## Interventions

- **DRUG:** Octafibrin
- **DRUG:** Cryoprecipitate

## Key facts

- **NCT ID:** NCT03037424
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-22
- **Primary completion:** 2018-11-30
- **Final completion:** 2019-03-27
- **Target enrollment:** 827 (ACTUAL)
- **Last updated:** 2019-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03037424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03037424, "FIBrinogen REplenishment in Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03037424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*